Dopexamine and cellular immune fuctions during systematic inflammation

Immunobiology

Volumn 208, Issue 5, 2004, Pages 429-438

  Oberbeck, Reiner ^a   Schmitz, Daniel ^a   Schüler, Mark ^a   Wilsenack, Klaus ^a   Schedlowski, Manfred ^a   Exton, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPEXAMINE; DRUG RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CIRCULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ANTAGONISM; DRUG DOSE REGIMEN; DRUG IMPLANTATION; DRUG INFUSION; IMMUNOMODULATION; LEUKOCYTE; MALE; MONITORING; MORTALITY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; SEPSIS; SPLEEN CELL; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 1942518895     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00290     Document Type: Article

References (42)

1. Baker CC, Chaudry IH, Gaines HO and Baue AE. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94: 331-335.
2. Baker CC, Oppenheimer L, Stephens B, Lewis FR and Trunkey DD. 1988. Epidemiology of trauma death. Am. J. Surg. 140: 144-148.
3. Basu S and Dasgupta PS. 2000. Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102: 113-124.
4. Behrendes E, Mollhoff T, Van Acken H, Schmidt C, Erren M, Deng MC, Weyand M and Loick HM. 1997. Effects of dopexamine on creatinine clearance, systemic inflammation and splachnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth. Analg. 84: 950-957.
5. Bennet ED. 1998. Dopexamine: much more than a vasoactive agent. Crit. Care Med. 26: 1621-1622.
6. Berk JL, Hagen JF, Maly G and Koo R. 1972. The treatment of shock with beta adrenergic blockade. Arch. Surg. 104: 46-51.
7. Blalock JE. 1994. The syntax of the immune-neuroendocrine communication. Immunol. Today 15: 504-511.
8. Byers RJ, Eddleston JM, Pearson RC, Bigley G and McMahon RFT. 1999. Dopexamine reduces the incidence of acute inflammation in the gut mucosa after abdominal surgery in high-risk patients. Crit. Care Med. 27: 1787-1793.
9. Cioca DP, Watanabe N and Isobe M. 2000. Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn. Heart J. 41: 385-398.
10. Cohen JJ. 1993. Apoptosis. Immunology Today 14: 126-130.
11. Crary B, Hauser SL, Borysenko M, Kutz I, Hoban C, Ault KA, Weiner HL and Benson H. 1983. Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans. J. Immunol. 131: 1178-1181.
12. Dahlof B, Andren L, Svensson A and Hansson L. 1983. Antihypertensive mechanism of beta-adrenoceptor antagonism - role of beta 2-blockade. J. Hypertens. 1(Suppl): 112-115.
13. Deitch EA. 1990. Intestinal permeability is increased in burn patients shortly after injury. Surgery 107: 411-416.
14. DiCarlo S, Blair RW, Bishop VS and Stone HL. 1988. Role of beta2-adrenergic receptors on coronary resistance during exercise. Am. J. Physiol. 64: 2287-2293.
15. Exton MS, Hörsten S, Schulte M, Vöge J, Strubel T, Donath S, Nagel E, Westermann J and Schedlowski M. 1998. Behaviourally conditioned immunosuppression using cyclosporine A. J. Neuroimmunol. 88: 182-191.
16. Fraser J, Nadeau J, Robertson D and Wood AJJ. 1981. Regulation of human leukocyte beta receptors by endogenous catecholamines. J. Clin. Invest. 67: 1777-1784.
17. Halmagyi DFJ, Kennedy M, Goodman AH and Varga D. 1971. Simple and combined adrenergic receptor blockade in canine endotoxinemia. Eur. Surg. Res. 3: 326-339.
18. Jakob SM and Takala J. 2000. Gut perfusion in the critically ill. Int. Care Med. 26: 813-815.
19. Johnson HM, Downs MO and Pontzer CH. 1992. Neuroendocrine peptide hormone regulation of immunity, in: Blalock JE (Ed), Neuroimmunoendocrinology, Chem. Immunol. Basel, Karger, Vol. 52, pp. 1-24.
20. Josefsson E, Berquist J, Ekam R and Tarkowski A. 1996. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88: 140-146.
21. Kawashima K and Fujii T. 2003. The lymphocytic cholinergic system and its biological function. Life Sci. 72: 2101.
22. Keel M, Ungethum U, Steckholzer U, Niederer E, Hartung T, Trentz O and Ertel W. 1997. Interleukin-10 counter-regulates proinflammatory cytokine-induced neutrophil apoptosis during severe sepsis. Blood 90: 3356-3363.
23. Kirby RF, Novak CM, Thunhorst RL and Johnson AK. 1992. The role of β1 and β2 adrenoceptors in isoproterenol-induced drinking. Brain Res. 656: 79-84.
24. Landmann R, Portenier M, Staehelin M, Wesp M and Box R. 1992. Beta-adrenergic receptors in human leukocyte subpopulations. Eur. J. Clin. Invest. 22: 30-36.
25. Lemoine H, Ehle B and Kaumann AJ. 1985. Direct labeling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118.551 and blocking potency of ICI 118.551. Naunyn. Schmiedebergs Arch. Pharmacol. 331: 40-51.
26. Luecken LJ and Lysle DT. 1992. Evidence for the involvement of β-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 38: 209-220.
27. Meakins JL and Marshall JC. 1986. The gastrointestinal tract: the motor of multiple organ failure. Arch. Surg. 121: 197-201.
28. Murphy RJL, Gardiner PF, Rousseau G, Bouvier M and Beliveau L. 1997. Chronic β-blockade increases skeletal muscle β-adrenergic-receptor density and enhances contractile force. Am. J. Physiol. 83: 459-465.
29. Oberbeck R, Dahlweid M, Koch R, van Griensven M, Emmendörfer A, Tscherne H and Pape HC. 2001. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit. Care Med. 29: 380-384.
30. Oberbeck R, van Griensven M, Nickel M, Tschernig T, Wittwer T and Pape HC. 2002. Influence of β-adrenoceptor antagonists on hemorrhage-induced cellular immune suppression. Shock 18: 331-335.
31. Qiu Y, Peng Y and Wang J. 1996. Immunoregulatory role of neurotransmitters. Adv. Neuroimmunol. 6: 223-231.
32. Ralph CJ, Transer SJ, Macnaughton PD and Sinclair DG. 2002. A randomised controlled trial investigating the effect of dopexamine on gastrointestinal function and organ dysfunction in the critical ill. Int. Care Med. 28: 884-890.
33. Rook GAW, Hernandez-Pando R and Lightman SL. 1994. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 imbalance. Immunol. Today 15: 301-323.
34. Schedlowski M, Hosch W, Oberbeck JR, Benshop RJ, Jacobs R, Raab HR and Schmidt RE. 1996. Catecholamines modulate human NK-cell circulation and function via spleen-independent β2-adrenergic mechanisms. J. Immunol. 156: 93-99.
35. Schmidt W, Häcker A, Gebhard MM, Martin E and Schmidt H. 1998. Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of β2-adrenoceptors. Crit. Care Med. 26: 1639-1645.
36. Sinclair DG, Houldsworth PE, Keogh B, Pepper J and Evans TW 1997. Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. Intensive Care Med. 23: 510-516.
37. Smith GW and O'Connor SE. 1998. An introduction to the pharmacological properties of dopexamine hydrochloride. Am. J. Cardiol. 62: 9C-17C.
38. Takala J, Meier-Hellmann A, Eddlestone J, Hulstaert P and Scramek V. 2000. Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study. Crit. Care Med. 28: 3417-3423.
39. Teschemacher A, Reinhardt D and Lemoine H. 1998. Do parasympatholytic effects of long beta 2-sympathomimetics contribute to their relaxant effects in airway smooth mus8e cells? Pulm. Pharmacol. Ther. 11: 253-261.
40. Vermes I, Haanen H, Steffens-Nakken H and Reutlingsperger CP. 1993. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled Annexin V. J. Immunol. Methods 184: 39-51.
41. Waydhas C, Nast-Kolb D, Jochum M, Trupka A, Lenk S, Fritz H, Duswald KH and Schweiberer L. 1992. Inflammatory mediators, infection, sepsis and multiple organ failure after severe trauma. Arch. Surg. 127: 460-467.
42. Wong GC and Clark SC. 1988. Multiple actions of interleukin 6 within a cytokine network. Immunol. Today 9: 137-139.